12:00 AM
 | 
Nov 12, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Kaken, Valeant Pharmaceuticals sales and marketing update

Valeant disclosed in its 3Q12 earnings call that it expanded its deal with Kaken for IDP-108. Valeant now has global commercialization...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >